BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26284815)

  • 1. The longitudinal impact of depression on disability in Parkinson disease.
    Pontone GM; Bakker CC; Chen S; Mari Z; Marsh L; Rabins PV; Williams JR; Bassett SS
    Int J Geriatr Psychiatry; 2016 May; 31(5):458-65. PubMed ID: 26284815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
    Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
    J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of depressive symptoms in early Parkinson disease.
    Ravina B; Camicioli R; Como PG; Marsh L; Jankovic J; Weintraub D; Elm J
    Neurology; 2007 Jul; 69(4):342-7. PubMed ID: 17581943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of change in self-reported disability among persons with Parkinson's disease after 2 years of follow-up.
    Gazibara T; Kisic-Tepavcevic D; Svetel M; Tomic A; Stankovic I; Kostic V; Pekmezovic T
    Neurol Sci; 2017 Aug; 38(8):1415-1421. PubMed ID: 28502059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of disability and quality of life in mild to moderate Parkinson disease.
    Muslimovic D; Post B; Speelman JD; Schmand B; de Haan RJ;
    Neurology; 2008 Jun; 70(23):2241-7. PubMed ID: 18519873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in Parkinson's disease: a cross-sectional study focusing on non-motor symptoms.
    Kadastik-Eerme L; Rosenthal M; Paju T; Muldmaa M; Taba P
    Health Qual Life Outcomes; 2015 Jun; 13():83. PubMed ID: 26088201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression and disability in Parkinson's disease.
    Cole SA; Woodard JL; Juncos JL; Kogos JL; Youngstrom EA; Watts RL
    J Neuropsychiatry Clin Neurosci; 1996; 8(1):20-5. PubMed ID: 8845697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal evaluation of health-related quality of life of patients with Parkinson's disease.
    Visser M; Verbaan D; van Rooden S; Marinus J; van Hilten J; Stiggelbout A
    Value Health; 2009; 12(2):392-6. PubMed ID: 18657099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The course of functional decline in older people with persistently elevated depressive symptoms: longitudinal findings from the Cardiovascular Health Study.
    Lenze EJ; Schulz R; Martire LM; Zdaniuk B; Glass T; Kop WJ; Jackson SA; Reynolds CF
    J Am Geriatr Soc; 2005 Apr; 53(4):569-75. PubMed ID: 15817000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with depression in Parkinson's disease.
    Dissanayaka NN; Sellbach A; Silburn PA; O'Sullivan JD; Marsh R; Mellick GD
    J Affect Disord; 2011 Jul; 132(1-2):82-8. PubMed ID: 21356559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical phenotype of drug-naïve Parkinson's disease based on nonmotor symptoms.
    Lee HM; Lee SS; Kim M; Kang SH; Seo WK; Kim JH; Koh SB
    Arch Gerontol Geriatr; 2015; 61(3):517-22. PubMed ID: 26183203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressive disorder as a predictor of physical disability in old age.
    Kivelä SL; Pahkala K
    J Am Geriatr Soc; 2001 Mar; 49(3):290-6. PubMed ID: 11300240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors and course of health-related quality of life in Parkinson's disease.
    Forsaa EB; Larsen JP; Wentzel-Larsen T; Herlofson K; Alves G
    Mov Disord; 2008 Jul; 23(10):1420-7. PubMed ID: 18512757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
    Santos-García D; de la Fuente-Fernández R
    J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of impulse control disorders on disability and quality of life in Parkinson's disease patients.
    Phu AL; Xu Z; Brakoulias V; Mahant N; Fung VS; Moore GD; Martin A; Starcevic V; Krause M
    J Clin Neurosci; 2014 Jan; 21(1):63-6. PubMed ID: 24035421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between medical comorbidity and treatment outcomes in late-life depression.
    Oslin DW; Datto CJ; Kallan MJ; Katz IR; Edell WS; TenHave T
    J Am Geriatr Soc; 2002 May; 50(5):823-8. PubMed ID: 12028167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors of motor impairment, disability, and quality of life in newly diagnosed PD.
    Velseboer DC; Broeders M; Post B; van Geloven N; Speelman JD; Schmand B; de Haan RJ; de Bie RM;
    Neurology; 2013 Feb; 80(7):627-33. PubMed ID: 23345637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression in Parkinson disease: a disabling but neglected factor.
    Cantello R; Riccio A; Scarzella L; Leotta D; Bergamasco B
    Ital J Neurol Sci; 1984 Dec; 5(4):417-22. PubMed ID: 6530364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic and functional recovery in depression in later life.
    Collard RM; Wassink-Vossen S; Schene AH; Naarding P; Verhaak P; Oude Voshaar RC; Comijs HC
    Soc Psychiatry Psychiatr Epidemiol; 2018 Oct; 53(10):1071-1079. PubMed ID: 29923072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in disability in people with multiple sclerosis: a 10-year prospective study.
    Conradsson D; Ytterberg C; von Koch L; Johansson S
    J Neurol; 2018 Jan; 265(1):119-126. PubMed ID: 29159465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.